Innovative Mycoplasma hyopneumoniae protection with Hyogen^®, with proven PCV2 protection of Circovac^® now Ready To Mix, in a single injection

Hyogen^® is now available in a larger format
200ml vial = 100 doses

Discover the benefits of dual protection in a single injection

Equivalent virological, immunological and pathological outcomes vs. separate administration of Circovac^® and Hyogen^®1
- No significant difference in terms of body weight or average daily weight gain, percentage of Porcine Circovirus type 2 (PCV2)-positive pigs, histopathological scores or M. hyopneumoniae- compatible lung lesions when vaccines were combined or administered separately
Long-lasting duration of immunity, covering the whole finishing period
- Dual protection against PCV2 and M. hyopneumoniae at 23 weeks of age, demonstrated in a study comparing the efficacy of Circovac^® and Hyogen^® administered separately or in combination
One bottle to protect 100 piglets against 2 major diseases

A 2.5 mL dose/piglet
Ready to mix prior to administration
- The mixture provides a homogeneous, smooth and stable suspension
- Excellent mixability, viscosity and syringeability

Indicated for the active immunization of fattening pigs from 3 weeks of age to reduce the occurrence and severity of lung lesions caused by Mycoplasma hyopneumoniae infection²
- M. hyopneumoniae is considered one of the primary agents in the porcine respiratory disease complex³
- M. hyopneumoniae is highly prevalent in swine-producing areas, causing major economic losses³
Contains a recent and specific antigen derived from a relevant circulating North American field strain (the 2940 strain)
Contains Imuvant^TM with J5, an adjuvant that has been shown to effectively enhance antigen uptake and stimulate broad innate, humoral, and cell-mediated immunity⁴
Provides rapid onset of immunity (3 weeks)⁵
Offer a 26-week duration of immunity, providing lifelong protection to market pigs²
Assessed as most efficient M. hyopneumonia vaccine in reducing lung lesion scores in pigs in different surveys^6,7

Click here for complete product information

Inactivated whole PCV2 virus vaccine combined with a potent adjuvant⁸
Induces a strong and effective humoral and cell-mediated response that:
- Persists until the finishing period ends⁹
- Leads to a reduction in viral replication (i.e., viremia) and excretion (i.e., shedding)^10,11
Improves reproductive parameters, including number of live-born piglets¹²
Piglet vaccination with CIRCOVAC® boosts profitability¹³
- Lower mortality rates
- Improved average daily weight gain
- Fewer underweight animals

Click here for complete product information